Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
celiac disease
Pharma
Argenx calls it quits on Vyvgart Hytrulo Sjögren's disease trial
Shortly after teeing up Vyvgart Hytrulo for entry into another potential immunology niche, argenx has stumbled against a separate target.
Fraiser Kansteiner
Oct 8, 2026 10:44am
First Wave BioPharma comes ashore with new name
May 17, 2024 12:22pm
BioNTech, Sanofi, Takeda—Fierce Pharma Asia
Apr 7, 2023 5:00am
ImmusanT’s celiac disease vaccine nabs fast FDA review
Jan 9, 2019 9:50am
FiercePharmaAsia: Takeda, Ascletis, Sanofi, Sun and more
Jan 6, 2017 7:58am
